HIPEC in recurrent ovarian cancer patients: Morbidity-related treatment and long-term analysis of clinical outcome

Gynecologic Oncology

Volumn 122, Issue 2, 2011, Pages 221-225

  Fagotti, Anna ^a   Costantini, Barbara ^a   Vizzielli, Giuseppe ^a   Perelli, Federica ^a   Ercoli, Alfredo ^b   Gallotta, Valerio ^a   Scambia, Giovanni ^a   Fanfani, Francesco ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Abano Terme Clinic   (Italy)

Author keywords

Cytoreduction; HIPEC; Morbidity; Recurrent ovarian cancer; Survival

Indexed keywords

DOCETAXEL; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; DRUG SENSITIVITY; FEMALE; FOLLOW UP; HUMAN; HYPERTHERMIC INTRAOPERATIVE INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; MORBIDITY; MORTALITY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INJECTIONS, INTRAPERITONEAL; MIDDLE AGED; MORBIDITY; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; TREATMENT OUTCOME;

EID: 79960444747     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.04.008     Document Type: Article

References (26)

1. A.P. Heintz, F. Odicino, P. Maisonneuve, M.A. Quinn, J.L. Benedet, and W.T. Creasman Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynaecological cancer Int J Gynecol Obstet 95 2006 S161 S192
2. M.M. Leitao Jr., and D.S. Chi Surgical management of recurrent ovarian cancer Semin Oncol 36 2009 106 111
3. D.K. Armstrong, B. Bundy, L. Wenzel, H.Q. Huang, R. Baergen, and S. Lele Intraperitoneal cisplatin and paclitaxel in ovarian cancer N Engl J Med 354 2006 43
4. R.E. Bristow, I. Puri, and D.S. Chi Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis Gynecol Oncol 112 2009 265 274
5. T.C. Chua, T.D. Yan, A. Saxena, and D.L. Morris Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality Ann Surg 249 2009 900 907
6. T.C. Chua, G. Robertson, W. Liauw, R. Farrell, T.D. Yan, and D.L. Morris Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in EOC peritoneal carcinomatosis: systematic review of current results J Cancer Res Clin Oncol 135 2009 1637 1645
7. M. Deraco, F. Raspagliesi, and S. Kusamura Management of peritoneal surface component of ovarian cancer Surg Oncol Clin N Am 12 2003 561 583 (Pubitemid 36920086)
8. A. Fagotti, I. Paris, F. Grimolizzi, F. Fanfani, G. Vizzielli, and A. Naldini Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study Gynecol Oncol 113 2009 335 340
9. A. Fagotti, F. Fanfani, C. Rossitto, D. Lorusso, A.M. De Gaetano, and A. Giordano A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy Oncology 75 2008 152 158
10. P.H. Sugarbaker Peritonectomy procedures Ann Surg 221 1995 29 42
11. P.H. Sugarbaker Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer Curr Opin Obstet Gynecol 21 2009 15 24
12. D. Dindo, N. Demartines, and P.A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2004 205 213 (Pubitemid 38963009)
13. E. Kaplan, and P. Meyer Non parametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
14. G. Ferrandina, F. Legge, V. Salutari, A. Paglia, A. Testa, and G. Scambia Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations Eur J Cancer 42 2006 2296 2302 (Pubitemid 44307622)
15. J.S. Spratt, R.A. Adcock, M. Muskovin, W. Sherrill, and J. McKeown Clinical delivery system for intraperitoneal hyperthermic chemotherapy Cancer Res 40 1980 256 260 (Pubitemid 10140145)
16. O. Glehen, F. Kwiatkowski, P.H. Sugarbaker, D. Elias, E.A. Levine, and M. De Simone Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study J Clin Oncol 22 2004 3284 3292 (Pubitemid 41103684)
17. P.H. Sugarbaker New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 7 2006 69 76 (Pubitemid 43025395)
18. D.S. Alberts, P.Y. Liu, E.V. Hannigan, R. O'Toole, S.D. Williams, and J.A. Young Intraperitoneal cisplatinplus intravenous plus cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer N Engl J Med 335 1996 1950 1955 (Pubitemid 26428219)
19. M. Markman, B.N. Bundy, D.S. Alberts, J.M. Fowler, D.L. Clark-Pearson, and L.F. Carson Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group J Clin Oncol 19 2001 1001 1007 (Pubitemid 32176274)
20. D.K. Armstrong, B. Bundy, L. Wenzel, H.Q. Huang, R. Baergen, and S. Lele Intraperitoneal cisplatin and paclitaxel in ovarian cancer N Engl J Med 354 2006 34 43 (Pubitemid 43048949)
21. R.C. Rietbroek, P.J. van de Vaart, J. Haveman, F.A. Blommaert, A. Geerdink, and P.J. Bakker Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells J Cancer Res Clin Oncol 123 1997 6 12 (Pubitemid 26414189)
22. A.J. Witkamp, E. de Bree, R. Van Goethem, and F.A. Zoetmulder Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy Cancer Treat Rev 27 2001 365 374 (Pubitemid 34413980)
23. L. Bijelic, A. Jonson, and P.H. Sugarbaker Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer Ann Oncol 18 2007 1943 1950 (Pubitemid 350286229)
24. K. Galaal, R. Naik, R.E. Bristow, A. Patel, A. Bryant, and H.O. Dickinson Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer Cochrane Database Syst Rev 16 6 2010 Jun CD007822
25. G. Ferrandina, M. Ludovisi, R. De Vincenzo, V. Salutari, D. Lorusso, and M. Colangelo Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study Ann Oncol 18 2007 1348 1353 (Pubitemid 47305008)
26. M. Markman, J. Markman, K. Webster, K. Zanotti, B. Kulp, and G. Peterson Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design J Clin Oncol 22 2004 3120 3125 (Pubitemid 41103725)